Clinical update on hormone replacement therapy

British Journal of Nursing

Volumn 19, Issue 8, 2010, Pages 496-504

  Holloway, Debra ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Hormone replacement therapy; HRT; Menopause

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; ESTROGEN THERAPY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; METHODOLOGY; NURSING; PATIENT EDUCATION; PATIENT SELECTION; POSTMENOPAUSE OSTEOPOROSIS; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; RISK FACTOR; UNCERTAINTY; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; UNCERTAINTY; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

EID: 77954892956     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2010.19.8.47634     Document Type: Article

References (29)

1. BeralV MillionWomen Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 326(9382): 419-27
2. Erratum in: Lancet (2003) 362(9390): 1160
3. Brockie J (2006) An alternative approach to the menopause. The Obstetrician and Gynaecologist 8(2) 96-102
4. Brockie J (2008) Physiology and effects of the menopause. Nurse Prescribing 6(5): 202-7
5. Canonico M, Oger E, Plu-Bureau G et al (2007) Hormone replacement therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen and progestogens: the ESTHER study. Circulation 115(7): 840-5
6. Currie H (2008) Assessing CVD risk after the menopause. Practice Nursing 19(7): 335-8
7. Greendale GA, Gold EB(2005) Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy. Am J Med 118(Suppl 12B): 148-54
8. Holmberg L, Anderson H, HABITS steering and data monitoring committees (2004) HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped. Lancet 363(9407): 453-5 (Pubitemid 38210063)
9. Howes LG, Howes JB, Knight DC (2006) Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 55(3): 203-211
10. International Menopause Society (2008) HRT in the Early Menopause: Scientific Evidence and Common Perceptions. Summary of the First IMS Global Summit on Menopause-Related Issues. IMS, Lancaster
11. Kenemans P Bundred NJ, Foidart JM et al; LIBERATE Study Group (2009) Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10(2): 135-46
12. Kim KH, Kang KW Kim DI et al (2010) Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women-a multicenter randomized clinical trial. Menopause 17(2): 269-80
13. Kongnyuy EJ, Norman R, Flight IHK, Rees MC (1999) Oestrogen and progestrogen HRT for peri-menopausal and post-menopausal women, weight and body fat distribution. Cochrane Database of Systematic Reviews, 3. www2.cochrane.org/reviews/en/ab001018.html
14. Lobo RA (2004) Evaluation of the cardiovascular event rate with hormonetherapy in healthy, early postmenopausal women: results from 2 large clinical trials. Arch Intern Med 164(5) 482-4
15. Lindh-Astrand L, Nedstrand E, Wyon Y, Hammar M (2004) Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy. Maturitas 48(2): 97-105
16. Lindh-Astrand L, Bixo M, Hirschberg AL, Sundström-Poromaa I, Hammar M (2010) A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms. Menopause 17(1): 72-9
17. MacLennan A, Lester S, Moore V (2001) Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 4(1): 58-74
18. MacLennan AH (2007) HRT: a reappraisal of the risks and benefits. Med J Aust 186(12): 643-6
19. Medicines and Healthcare products Regulatory Agency (2007) Hormone-replacement therapy: updated advice. Drug Safety Update 1(2). MHRA, London. www.mhra.gov.uk/Publications/Safetyguidance/DrugSafetyUpdate/ CON2032234
20. Nelson HD, Vesco KK, Haney E et al (2006) Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis .JAMA 295(17): 2057-71
21. Oehler MK, Mackenzie I, Kehoe S, Rees MC (2003) Assessment of abnormal bleeding in menopausal women: an update.J Br Menopause Soc 9(3): 117-20, 121
22. Peeyananjarassri K, Baber R (2005) Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric 8(1): 13-23
23. Rees M, Stevenson J, Hope S, Rozenburg S, Palacios SD (2009) Management of the Menopause-the Handbook. 5th edn. British Menopause Society, Royal Society of Medicine, London
24. Rossouw JE, Prentice RL, Manson JE et al 2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297(13); 1465-77.
25. Erratum JAMA (2008) 299(12):1426
26. Tankó LB, Christiansen C (2004) An update on the antiestrogenic effect of smoking. A literature review with implications for researchers and practitioners. Menopause 11(1): 104-9
27. Uygur D, Yeşildaglar N, Erkaya S (2005) Effect on sexual life-a comparison between tibolone and continuous combined conjugated equine oestrogens and medroxyprogesterone acetate. Gynecol Endocrinol 20(4): 209-12
28. Writing group for the Women's Health Initiative; Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3): 321-33
29. Women's Health Initiative Steering Committee; Anderson GL, Limacher M, Assaf AR et al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291(14); 1701-12